ScienceDex / Researcher record
Louise Henderson
- University of North Carolina at Chapel Hill · Otolaryngology (NIH department code)
- University of North Carolina at Chapel Hill · Radiology (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- Program Leader
- Top 5% Funded
- R01 Holder
- Early Career
- Diverse Portfolio
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,756,344 | 6 | #3,063 |
| 2025 | $4,333,055 | 7 | #1,801 |
| 2026 | $12,267,270 | 7 | #560 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20246 records
- FY20257 records
- FY2026 · selected7 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6970058Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0001-8356-9267Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Otolaryngology
- Internal Medicine
- Radiology
- Public Health
FY2026 award records by amount
NIH award records listing Louise Henderson as a PI. Multi-PI records show the full award amount for context.
- 4P30CA016086-50P30Contact PICancer Center Support GrantUniversity of North Carolina at Chapel Hill · Otolaryngology (NIH department code)$8.2Maward amount
- 5UG1CA286949-03UG1Co-investigatorCancer Screening Research Network - North Carolina Hub (CSRN-NC HUB)University of North Carolina at Chapel Hill · Internal Medicine (NIH department code)$1Maward amount
- 5R01CA298002-02R01Contact PIOPTimizing surveillance in lung cancer survivors with novel IMAging biomarkers and deep-Learning (OPTIMAL)University of North Carolina at Chapel Hill · Radiology (NIH department code)$927.5Kaward amount
- 5R01CA212014-09R01Contact PIEvaluating Lung Cancer Screening Patterns and Outcomes in Diverse Populations and SettingsUniversity of North Carolina at Chapel Hill · Radiology (NIH department code)$691.2Kaward amount
- 5R01CA285976-03R01Contact PILung Cancer Screening: Cumulative Risk and Multilevel Impact of False Positive FindingsUniversity of North Carolina at Chapel Hill · Radiology (NIH department code)$644.2Kaward amount
- 1R21CA313041-01R21Co-investigatorEarly detection of liver cancer among patients with cirrhosis and MASLDUniversity of North Carolina at Chapel Hill · Internal Medicine (NIH department code)$399.8Kaward amount
- 5R01CA277756-04R01Co-investigatorApplying causal inference methods to improve estimation of the real-world benefits and harms of lung cancer screeningUniversity of North Carolina at Chapel Hill · Public Health (NIH department code)$355.7Kaward amount
Award organization
Organizations that administered FY2026 awards listing Louise Henderson as a PI.
FY2026 award administered by University of North Carolina at Chapel Hill (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of North Carolina at Chapel Hill
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3063
- 2024Entered Top 25% NationallyRanked #3063
- 2025$5M Cumulative Funding
- 2025Entered Top 10% NationallyRanked #1801
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
- 2026$10M Cumulative Funding
- 2026Entered Top 5% NationallyRanked #560
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Louise Henderson.